25 мар. 2024 г. · Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up to 1.025 billion Euros, including an upfront payment and additional ...

25 мар. 2024 г. · Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to. 1.025 billion Euros, including an upfront payment and ...

25 мар. 2024 г. · Denmark's Novo Nordisk said on Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen ...

26 мар. 2024 г. · Novo Nordisk announced that it has acquired Cardior Pharmaceuticals in hopes of improving its pipeline in cardiovascular disease management.

25 мар. 2024 г. · Novo Nordisk has agreed to acquire its portfolio company Cardior Pharmaceuticals for up to 1.025 billion Euros, including an upfront payment and additional ...

25 мар. 2024 г. · Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease. March 25, 2024 05:59 ET

25 мар. 2024 г. · The Danish drugmaker will pay up to $1.025 billion to buy the biotech company, which specializes in a type of RNA therapy.

25 мар. 2024 г. · The drugmaker has agreed to buy Cardior Pharmaceuticals and its midphase prospect in a deal that could top out above 1 billion euros.

25 мар. 2024 г. · The up to €1bn acquisition of Cardior Pharmaceuticals will strengthen Novo Nordisk's pipeline in cardiovascular disease.

25 мар. 2024 г. · Novo Nordisk on Monday announced that it will acquire German biotech Cardior Pharmaceuticals in a bid to boost its cardiovascular disease portfolio.